Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping
Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping
复制标题
通过全肽图谱从血清中获取幽门螺杆菌 CagA 抗体的表位肽
DOI:
10.1007/s00535-019-01584-8
复制
发表时间:
2019
期刊:
影响因子:
--
通讯作者:
Shamshul Ansari ; Junko Akada; Yuichi Matsuo; Seiji Shiota; Yoko Kudo; Tadayoshi Okimoto; Kazunari Murakami; Yoshio Yamaoka
中科院分区:
文献类型:
--
作者:
Ansari Shamshul;Yamaoka Yoshio;Shamshul Ansari ; Junko Akada; Yuichi Matsuo; Seiji Shiota; Yoko Kudo; Tadayoshi Okimoto; Kazunari Murakami; Yoshio Yamaoka
BackgroundHelicobacter pyloriCagA has been found to be immuno-dominant protein and utilized for the diagnosis of the infection withcagA-positive strains. It is important to characterize the peptide epitopes capable of detecting serum anti-CagA antibodies to understand CagA immunogenicity.MethodsSera from 171 Japanese patients were subjected for the epitope mapping study. Eighty seven peptides were designed from the CagA consensus sequence and were used for ELISA protocol to test the serum samples. The reacting anti-CagA IgG amounts to specific peptides were measured and compared.ResultsThe study revealed a strong reactivity of two peptides (c7-NNTEPIYAQVNKKKAGQAT and c8-AGQATSPEEPIYAQVAKKV) inH. pylori-infected group. Interestingly, these two peptides contained the well-known EPIYA-A and EPIYA-B region, respectively, which are two out of three CagA phosphorylation domains. Tyrosine-phosphorylation of these peptides reduced their reactivity in most sera. Moreover, additional peptides’ mapping and chimeric-peptides’ experiments indicated that the amino acids (QV and KK) accommodated in right-side flanking regions of both EPIYA-motifs were essential for their strong reactivity, whereas the third EPIYA-motif containing peptide (c12-GRSASPEPIYATIDFDEA) with differing flanking amino acids was not reactive in most cases.ConclusionsOur results suggest that the amino acid sequences constituted in the two reactive peptides are the important immunogenic regions of CagA which would be useful to develop next-generation peptide-based diagnostic assays.